kr394.80
3.35% today
Copenhagen, Oct 27, 04:59 pm CET
ISIN
DK0060336014
Symbol
NSIS B
Sector
Industry

Novonesis Stock price

kr394.80
+12.60 3.30% 1M
-16.20 3.94% 6M
-12.90 3.16% YTD
-50.90 11.42% 1Y
+1.40 0.36% 3Y
+3.80 0.97% 5Y
+90.10 29.57% 10Y
+328.20 492.79% 20Y
Copenhagen, Closing price Mon, Oct 27 2025
-13.70 3.35%
ISIN
DK0060336014
Symbol
NSIS B
Sector
Industry

Key metrics

Basic
Market capitalization
kr190.0b
Enterprise Value
kr212.0b
Net debt
kr22.1b
Cash
kr2.7b
Shares outstanding
465.6m
Valuation (TTM | estimate)
P/E
45.1 | 29.7
P/S
6.2 | 6.0
EV/Sales
6.9 | 6.7
EV/FCF
49.9
P/B
2.4
Dividends
DPS
kr6.20
Yield 1Y | 5Y
1.5% | 1.5%
Growth 1Y | 5Y
0.0% | 3.4%
Payout 1Y | 3Y
124.8% | 63.3%
Increased
0 Years
Financials (TTM | estimate)
Revenue
kr30.6b | kr31.5b
EBITDA
- | kr11.7b
EBIT
kr7.0b | kr7.9b
Net Income
kr4.2b | kr6.4b
Free Cash Flow
kr4.2b
Growth (TTM | estimate)
Revenue
34.5% | 10.0%
EBITDA
- | 86.0%
EBIT
73.2% | 61.3%
Net Income
99.5% | 180.7%
Free Cash Flow
192.5%
Margin (TTM | estimate)
Gross
53.2%
EBITDA
- | 37.3%
EBIT
22.7%
Net
13.8% | 20.4%
Free Cash Flow
13.9%
Financial Health
Equity Ratio
73.6%
Return on Equity
2.7%
ROCE
6.1%
ROIC
4.6%
Debt/Equity
0.3
More
EPS
kr9.1
FCF per Share
kr9.1
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Novonesis a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,039 stocks worldwide.

Novonesis Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Novonesis forecast:

15x Buy
68%
5x Hold
23%
2x Sell
9%

Analyst Opinions

22 Analysts have issued a Novonesis forecast:

Buy
68%
Hold
23%
Sell
9%

Financial data from Novonesis

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
30,615 30,615
35% 35%
100%
- Direct Costs 14,319 14,319
18% 18%
47%
16,296 16,296
53% 53%
53%
- Selling and Administrative Expenses 6,264 6,264
46% 46%
20%
- Research and Development Expense 3,254 3,254
33% 33%
11%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 6,955 6,955
73% 73%
23%
Net Profit 4,219 4,219
100% 100%
14%

In millions DKK.

Don't miss a Thing! We will send you all news about Novonesis directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.

Head office Denmark
CEO Ester Baiget
Website www.novozymes.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today